
CAS 152551-75-2
:Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone
CAS:Formula:C19H27N5O4Color and Shape:SolidMolecular weight:389.4488Terazosin EP Impurity J
CAS:Formula:C19H27N5O4Color and Shape:White To Off-White SolidMolecular weight:389.461-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone
CAS:Controlled Product<p>Impurity Terazosin EP Impurity J<br>Applications 1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone (Terazosin EP Impurity J) is an impurity of Terazosin (T105000), an α-1-adrenergic blocker that is related to Prazosin (P702325).<br>References Blom, Y., et al.: J. Chromatograph., 653, 138 (1993);<br></p>Formula:C19H27N5O4Color and Shape:NeatMolecular weight:389.451-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone-d8
CAS:Controlled Product<p>Applications Isotope labelled 1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone s an impurity of Terazosin (T105000), an α-1-adrenergic blocker that is related to Prazosin (P702325).<br>References Blom, Y., et al.: J. Chromatograph., 653, 138 (1993);<br></p>Formula:C19D8H19N5O4Color and Shape:NeatMolecular weight:397.4981-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone
CAS:<p>1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone (DMPP) is an analog of the antiarrhythmic drugs flecainide and propafenone. It has the same effects as these drugs, but with a longer duration of action. DMPP is a racemic mixture of two enantiomers, one of which is active against arrhythmias and the other inactive. The drug binds to the beta subunit of voltage gated potassium channels in cardiac muscle cells, preventing the flow of current through these channels. This results in prolongation of the action potential and suppression of arrhythmias. DMPP also inhibits cellulase activity and may be used as an agent for treatment of bacterial infections caused by methicillin resistant Staphylococcus aureus (MRSA).</p>Formula:C19H27N5O4Purity:Min. 95%Molecular weight:389.45 g/mol




